SLAS 2026

Visit Corning's Booth #1723 at SLAS 2026 to see the latest solutions for drug discovery and lab automation with a focus on 3D cell culture. We invite you to learn more about our solutions in our exhibit, including:

We believe that helping our customers make the transition from 2D to 3D, whether for a target discovery, lead identification and optimization, or in high throughput screening, will greatly accelerate drug discovery.

The use of 3D cell culture models has dramatically increased, and they can mimic the specificity of native tissue with greater physiological relevance than conventional 2D cultures. This is particularly evident in applications such as stem cell culture and differentiation, cancer biology, drug and toxicity screening, and tissue engineering. Whether you're just getting started in 3D cell culture, looking for proven ways to scale up, or moving to high throughput screening, explore Corning's 3D cell culture tools at SLAS2026.

Our new Axygen® PCR microplates have an industry standard footprint enabling the compatibility with automated liquid handlers and most thermal cyclers. Each microplate is engineered to stay warp-free, provide precise positioning for automation, and deliver pressure resistance without distortion. The plate is the latest addition to a large portfolio of automation consumables including the extensive range of Axygen automation tips for liquid handling.

Our full portfolio of glass-bottom and COC film-bottom microplates are ideal for high-content screening and imaging applications. These high-optical quality microplates provide industry-leading flatness that reduces autofocus time, increases throughput, and improves high-content screening assay performance.

Technical Program

Sunday, February 8, 2026
TitleTimeLocation
Course: Mastering 3D Cell Culture: A Practical Toolbox from Research to High Throughput8:30 AM – 4:30 PM107B

Speakers:

  • Hilary Sherman, Corning Life Sciences, Application Specialist
  • Oksana Sirenko, Ph.D., Molecular Devices
  • Dennis Plenker, Ph.D., Xilis Inc
  • Angeline Lim, Ph.D., Molecular Devices
  • Tim Spicer, Ph.D., The Wertheim UF Scripps Institute
 

To 3D or not to 3D – this is a question at the forefront for most people in discovery programs. With the passing of the FDA Modernization Act 2.0, there is a greater interest in the community around the use of physiologically relevant in vitro models as New Approach Methods (NAM) for the use of IND enabling submissions to the FDA.

This workshop is designed to help participants understand the nuts and bolts of setting up 3D physiologically relevant models, will allow participants to understand not only the utility of these models in answering a specific biological question but also to understand the practical importance of the various stages of assay development, automation compatibility, high content imaging and data analysis. Without a robust, scalable and reproducibly functioning assay there is no actionable data. At the end of this workshop, participants should be able to leave with the confidence of understanding the importance of robust and scalable assay development for 3D models and how that will allow them to position and prioritize pre-clinical candidates in their discovery programs.

 
Monday, February 9, 2026
TitleDescription/DetailsPresented ByTimeLocation
Temperature-Controlled Liquid Handling and Axygen Consumables Enable Repeatable Pancreatic Cancer Organoid Assays
Automation Technologies Track
Poster Presentations: Session B

Hilary Sherman, Corning Life Sciences, Application Specialist

2:00 - 3:00 PMExhibit Halls AB
De-Risking Neurotherapeutics Discovery with AI-Powered Human Brain OrganoidsBrainStorm Therapeutics is harnessing patient iPSC-derived brain organoids to model complex neurological diseases with unprecedented accuracy. Traditional animal and cell models often fail to capture the intricacies of human brain biology, limiting therapeutic success. Our platform generates 3D brain organoids from patient iPSCs that faithfully recapitulate disease-relevant cell types, neural circuits, and phenotypes, including dopaminergic neuron loss and lipid metabolism defects seen in Parkinson’s disease. These models serve as a foundation for high-content screening, transcriptomic profiling, and functional analysis, enabling us to uncover both generalizable and mutation-specific disease mechanisms. By layering in AI tools trained on multimodal biological data, we enhance our ability to map dysregulated pathways and prioritize therapeutic targets. Our “clinical trial in a dish” approach supports more predictive and patient-relevant drug testing, reducing cost and risk in early-stage R&D. We are extending this organoid-based platform to additional brain disorders like Rett Syndrome and CDKL5 Deficiency Disorder, with the goal of delivering precision treatments rooted in human biology.Maya Gosztyla, Ph.D., Co-Founder and Chief Scientific Officer, Brainstorm Therapeutics4:00 - 4:20 PMExhibition Hall: Solutions Spotlight Theater

Featured Products

Axygen® PCR Microplates

Axygen® PCR Microplates

Our new Axygen PCR microplates have an industry standard footprint enabling the compatibility with automated liquid handlers and most thermal cyclers. Each microplate is engineered to stay warp-free, provide precise positioning for automation, and deliver pressure resistance without distortion.

Learn More

Transwell® Permeable Supports

Microplates

Corning® and Falcon® microplates are ideal for drug discovery applications, including assay prep, assay development, and HTS and automation.

Learn More

Automation Tips

Automation Tips

Corning is your source of high quality automation tips for automated liquid handling equipment.

Learn More

Microplates

Transwell® Permeable Supports

Create in vivo-like cell culture environment using Transwell permeable supports to enhance cell growth for both anchorage-dependent and feeder-independent cell lines.

Order Now

Organoid Counting Software for the Corning Cell Counter

Corning® 96- and 384-Well Spheroid Microplates

Corning spheroid microplates feature an ultra-low attachment surface. This surface treatment inhibits specific and nonspecific immobilization, which forces cells into a suspended state thus allowing for 3D spheroid formation. 

Order Now

Organoid Counting Software for the Corning Cell Counter

Organoid Counting Software for the Corning Cell Counter

Corning's automated cell counting software for the Corning Cell Counter provides 3D capabilities for automated cell counting of organoids.

Learn More

Organoid Counting Software for the Corning Cell Counter

Corning® 96- and 384-Well Spheroid Microplates

Corning spheroid microplates feature an ultra-low attachment surface. This surface treatment inhibits specific and nonspecific immobilization, which forces cells into a suspended state thus allowing for 3D spheroid formation. 

Order Now